Apton "Acquired 10 billion won worth of GPCR stock... 12.2% stake"
⚡ Quick Summary
(Seoul = Yonhap News) Apton [270520], a KOSDAQ listed company, acquired 1,428,571 shares of GPCR, a new drug research and development company using biotechnology techniques, for approximately KRW 10 billion...
📰 Related Articles
“Safety warning issued for damage to digestive organs, including abdominal pain, from ‘obesity treatment injection’”
Khan
Financial Supervisory Service, on-site inspection of Shinhan and Kiwoom Securities...check for mis-selling of JTBC corporate bonds
Khan
Woman sentenced to 4 years in prison for threatening Son Heung-min with pregnancy, male accomplice sentenced to 2 years
Yonhap
Medical Association “Participates in medical support at Venezuela earthquake sites”
Yonhap
KB Finance unveils ‘free admission project’ at popular museums and art galleries… 1st place: Gimcheon City Museum
Donga